WinstonWınston
Back
Stock

Vext Science

VEXTF
18
Drug Manufacturers - Specialty & Generic · Healthcare
Price
$0.18
-0.02 (-7.85%)
Market Cap
$44.3M
Exchange
Other OTC
Winston Score
18
Winston is worried
Weak fundamentals across most pillars.
Data as of Sep 11, 2026 · filings through Jun 30, 2026

§How the score breaks down

Quality
Weak
Growth
Mixed
Cash Flow
Weak
Stability
Mixed
Valuation
Data not available

Share count rising — dilution

+69.1% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 146.4M (2021) → 247.6M (2025)

§Winston Score History

The full picture

Vext Science, Inc. operates as a comprehensive enterprise within the United States' cannabis sector, encompassing agricultural technology, various services, and property management. The company is actively involved in cultivating, extracting, manufacturing, and distributing a range of THC and CBD products, including vape cartridges, concentrates, and edibles. Beyond production, it also manages retail dispensaries and handles the wholesale distribution of cannabis-derived THC and hemp-derived CBD products, marketed under its Vapen and Pure Touch Botanicals brands. Furthermore, its Vapen Kitchens line offers a diverse selection of infused edibles, such as Vapen clear products, THC chocolate bars, syrups, snacks, and various candies, including gummies. Established in 2015, the company was formerly known as Vapen MJ Ventures Corporation until it rebranded to Vext Science, Inc. in November 2019, with its headquarters situated in Phoenix, Arizona.

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

-11.9% YoY

YoY Growth Rate

Revenue declining

EPS Growth

+78.3% YoY

YoY Growth Rate

EPS growth accelerating

R&D Spend

$0/ year

0.0% of revenue

Below sector average (18%)

Research and development spending

Cash Runway

~5 years

$5M cash & investments

Quarterly Free Cash Flow

→ Burn rate stable

$5M cash & investments at current burn rate

Revenue declining

Vext Science's revenue is actually shrinking. In a growth stock, that removes the core investment thesis. The low Winston Score here may be warranted — unless there's a turnaround story.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
14.9%
Thin — 14.9% gross margin
Profit after running costs
Operating Margin
-14.8%
Losing money on operations — -14.8%
Return on the money invested
ROCE
-10.9%
Weak — -10.9% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
+14.2%
Fast-growing sales (+14.2% YoY)
Profit growth
EPS YoY
N/A
Data not available
How steady the profit is
EPS Consistency
5/8 quarters
Mixed — about half the quarters showed growth

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
N/A
Data not available
Spare cash per sale
FCF Margin
6.9%
Modest free cash flow (6.9%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
0.57
Conservative — low debt load (0.57)
Covers its interest
Interest Cover
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
N/M
Negative earnings — P/E not meaningful
Cheaper or dearer next year
P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial